Blog Post Life Sciences Diversity, Equity + Inclusion Closing Disparity Gaps to Achieve Kidney Health Equity At the 8th Annual Women of Color in Pharma (WOCIP) Conference, Clarkston’s Erica Parks Murray connected with dozens of industry ...
Blog Post Diversity, Equity + Inclusion Life Sciences Clinical Trial Diversity and Inclusive Research: Guidance from the FDA and ICER At the 8th Annual Women of Color in Pharma (WOCIP) Conference earlier this month, Clarkston’s Erica Parks Murray connected with ...
Blog Post Diversity, Equity + Inclusion Ensuring Health Equity through Precision Medicine At the 8th Annual Women of Color in Pharma (WOCIP) Conference last month, Clarkston’s Erica Parks Murray connected with dozens ...
Blog Post Diversity, Equity + Inclusion Life Sciences Achieving Health Equity in 2025: Additional Takeaways from the WOCIP Conference Clarkston’s Erica Parks Murray, LaToya Lee Jones, and Brandon Miller recently attended the 8th Annual Women of Color in Pharma ...
Blog Post Diversity, Equity + Inclusion Life Sciences Key Takeaways from WOCIP’s 8th Annual Conference Clarkston’s Erica Parks Murray, LaToya Lee Jones, and Brandon Miller recently attended the 8th annual Women of Color in Pharma ...
Blog Post Diversity, Equity + Inclusion Pharma What to Expect at WOCIP’s 8th Annual Conference Women of Color in Pharma (WOCIP) is a non-profit organization dedicated to promoting the development and advancement of women of ...
Blog Post Life Sciences Diversity, Equity + Inclusion Exploring the Evolution of Health Equity in Clinical Trial Regulations In an ongoing evolution of equitable clinical trials, as of June 26, 2024, the FDA has issued a draft guidance, ...
Blog Post Life Sciences Diversity, Equity + Inclusion Advancing Health Equity in Pharma: Key Themes from the 2024 WOCIP Cluster Meetings Clarkston Consulting recently sponsored and attended this year’s 2024 Women of Color in Pharma (WOCIP) Cluster meetings, which focused, with ...
Blog Post Life Sciences Diversity, Equity + Inclusion Key Takeaways from the DEI in the Lab Panel at SLAS 2024 Clarkston’s Brandon Miller and Dmitri Serebrianik recently attended the 2024 Society for Laboratory Automation and Screening (SLAS) Conference in Boston, ...
Blog Post Life Sciences Diversity, Equity + Inclusion Top 3 Reasons Why You Need to Incorporate DEI into Clinical Trials Today Within the dynamic landscape of clinical trials, the incorporation of Diversity, Equity, and Inclusion (DE+I) into patient pools is frequently ...
Blog Post Digital Diversity, Equity + Inclusion Driving Progress in Pharma: Recapping the 2023 Women of Color in Pharma (WOCIP) Conference Clarkston’s Erica Parks Murray and LaToya Lee Jones recently attended the 7th annual Women of Color in Pharma (WOCIP) Conference ...
Blog Post Life Sciences Diversity, Equity + Inclusion Resources to Support and Promote DE+I in Clinical Trials Considering diversity, equity, and inclusion (DE+I) in clinical trials design and delivery allows investigators to more accurately detect a disease, ...
